Skip to main content
. 2016 Mar 22;19(2):233–240. doi: 10.1093/europace/euw052

Figure 2.

Figure 2

Patient flow diagram. Screening, enrolment, randomization, and inclusion into further analysis. One patient within the ibutilide group did not receive second study drug due to occurrence of recurrent nsVT.